CWF19L1 and glioblastoma: In order to assess the chromatin status of the CWF19L1 promoter in the GBM cell line, chromatin immunoprecipitation‐quantitative PCR (ChIP‐qPCR) analysis was performed using antibodies against H3K27ac and four genomic PCR primers against the CWF19L1 promoter.